{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-288468","form_type":"8-K","ticker":"FBLG","cik":"0001958777","company_name":"FibroBiologics, Inc.","filed_at":"2026-06-29T20:15:37+00:00","discovered_at":"2026-06-29T20:17:00.308860+00:00","generated_at":"2026-06-29T20:17:20.528741+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"FibroBiologics closes $3M private placement; warrants could add $6M","bullets":["Gross proceeds of $3.0M from sale of 4.08M shares/pre-funded warrants + warrants at $0.735/share.","Net proceeds ~$2.6M; warrants exercisable only after stockholder approval for up to 8.16M additional shares.","If all warrants exercised for cash, total gross proceeds could reach ~$9.0M.","H.C. Wainwright acted as placement agent, receiving 7% cash fee and 285,714 placement agent warrants.","Funds earmarked for working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-288468","json":"https://secwatch.observer/filing/0001193125-26-288468.json","markdown":"https://secwatch.observer/filing/0001193125-26-288468.md","text":"https://secwatch.observer/filing/0001193125-26-288468.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1958777/000119312526288468/0001193125-26-288468-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1958777/000119312526288468/fblg-20260625.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T20:17:20.528741+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}